Several biases can be noted in our study, mainly regarding the selection of patients, based on clinically and radiologically suspected NSCLC harboring an easily detectable “target” mutation, which was mainly represented by EGFR mutations at the time of our study. This evidence concerns the gene EGFR and non-small cell lung carcinoma.